Argentum Pharmaceuticals LLC vs. Cipla Limited
Explore the PTAB proceeding IPR2017-00807 filed by Argentum Pharmaceuticals LLC on 2017-02-02. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2017-00807
Filing Date
2017-02-02
Accorded Filing Date
2017-02-02
Institution Decision Date
2017-08-21
Last Modified Date
2022-09-23
Proceeding Type
IPR
Termination Date
2018-05-21
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Argentum Pharmaceuticals LLC
Represented By
Michael R. HoustonPatent Owner / Respondent
Cipla Limited
Represented By
Dennies VarughesePatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 (Biotechnology & Organic Chemistry)
Decisions Rendered
2 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 32363 | Gregory Maag | +1 713-238-8000 |
| 32846 | Daniel Stanger | +1 703-691-5648 |
| 37432 | James Ruland | +1 972-665-3605 |
| 39624 | Rodney Carroll | +1 972-731-2288 |
| 39800 | Michael Piper | +1 972-731-2284 |
| 45438 | Joseph Brown Jr | +1 972-731-2288 |
| 45475 | Michael Konczal | +1 972-731-2288 |
| 45962 | Donna Mason | +1 202-982-5609 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 13 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | Asserted | Asserted Patent | View Official Patent → |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐ฌ๐ง United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| ๐ฌ๐ง United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| ๐ PCT International (WIPO) | PCT World Application | View Official Patent → |
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited et al.
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited et al.